Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines-Reference-Cited by-同舟云学术

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

Published:2007-11 Issue:3 Volume:32 Page:159-168
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Elbayoumi Tamer A.,Torchilin Vladimir P.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer;Agus;Semin. Oncol.,2000

2. Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials;Alberts;Semin. Oncol.,2004

3. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates;Allen;Clin. Cancer Res.,2005

4. A single monoclonal antinuclear autoantibody with nucleosome-restricted specificity inhibits the growth of diverse human tumors in nude mice;Chakilam;Cancer Ther.,2004

5. Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies;Elbayoumi;Eur. J. Nucl. Med. Mol. Imaging,2006

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model;Drug Delivery and Translational Research;2024-03-20

2. Functionalized liposomes for targeted breast cancer drug delivery;Bioactive Materials;2023-06

3. Liposomes in Cancer Therapy: How Did We Start and Where Are We Now;International Journal of Molecular Sciences;2023-04-01

4. Immunoliposomes: A Targeted Drug Delivery System for Cancer Therapeutics and Vaccination;Current Pharmaceutical Biotechnology;2023-03

5. Cholesterol in drug delivery systems;Cholesterol;2022